Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes

Author: 
Dr Susannah Rowles
Date of the announcement: 
Friday, 19 November, 2021

ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes .
Apologies if you've had this update from multiple sources.
We are currently collating feedback on this decision from experts in this area, to share with ABCD members to ensure that people with Type 1 diabetes get the best care and can make informed decisions. 
 

Attachments: 

Information for HCPs

COVID-19 Information for Healthcare Professionals

ABCD Webinar Series

ABCD Webinars